IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2020 Holdings

Filed 2021-02-16 | 7 holdings | $1.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Relay Therapeutics, Inc.(RLAY)COM75943R102$438.5K10,551,11537.7%
Revolution Medicines, Inc.(RVMD)COM76155X100$278.1K7,024,03123.9%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$178.3K5,422,54915.3%
Pliant Therapeutics, Inc.(PLRX)COM729139105$132.7K5,839,16011.4%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$69.8K5,962,2026.0%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$45.7K6,391,1763.9%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$21.3K3,048,7801.8%